| 5FO2: Structure Of Human Transthyretin Mutant A108i reference: Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation., Sant'Anna R, Almeida MR, Varejao N, Gallego P, Esperante S, Ferreira P, Pereira-Henriques A, Palhano FL, de Carvalho M, Foguel D, Reverter D, Saraiva MJ, Ventura S, Sci Rep. 2017 Mar 24;7:44709. doi: 10.1038/srep44709. PMID: 28338000 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).